(Q43871655)

English

Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Vicente Soriano

8

object named as

Vincent Soriano

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Carmen de Mendoza

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

José Tomás Ramos

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Luis Ciria

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Claudia Fortuny

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Francisco José García

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

María Isabel de José

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Francisco Asensi

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

9-16

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 Team

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients.

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

1 reference

https://api.crossref.org/works/10.1310%2FFAJF-7A8G-QAR4-Q0X5

21 January 2018

Identifiers

10.1310/FAJF-7A8G-QAR4-Q0X5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43871655&oldid=2104064516"